EFNB2 and small cell lung carcinoma: EPHB2, as an EPHB subgroup receptor kinase, could modulate the biological behavior of small cell lung carcinoma through autocrine and/or juxtracrine activation by ephrin-B ligands (EFNB1, EFNB2, and EFNB3) that are expressed in the same or neighboring cells [28].